Business Context and Reporting Period
Company: RF Acquisition Corp III (RFAM)
Reporting Period: Quarter ended March 31, 2026 (Six months from inception on September 15, 2025).
Business Overview: The Company is a Cayman Islands exempted company formed as a Special Purpose Acquisition Company (SPAC) to effect a business combination with one or more businesses, focusing on deep technology sectors in Asia (AI, quantum computing, biotechnology). The Company consummated its Initial Public Offering (IPO) on February 17, 2026, and has not yet commenced operations or generated operating revenue.
Key Financial Metrics
| Metric | Value (as of/for period ended March 31, 2026) |
|---|---|
| Cash and Cash Equivalents | $933,390 |
| Cash Held in Trust Account | $100,403,232 |
| Total Assets | $101,417,975 |
| Net Income (3 Months) | $725,986 |
| Net Income (6 Months) | $673,033 |
| General & Administrative Costs (6 Months) | $152,199 |
| Interest Earned on Trust (6 Months) | $403,232 |
| Working Capital | $899,267 |
| Outstanding Public Shares | 10,000,000 |
Material Changes vs. Prior Period
The Company was incorporated on September 15, 2025, and had no operations prior to that date. Consequently, there are no corresponding prior-year interim periods for comparison. The financial position reflects the transition from a pre-IPO shell company to a post-IPO SPAC:
- Assets: Total assets increased from $113,494 (Sept 30, 2025) to $101,417,975 (March 31, 2026), driven primarily by the placement of $100,000,000 into the Trust Account following the IPO.
- Equity: Shareholders' equity increased from $8,922 to $899,267, reflecting the issuance of Public Shares, Private Placement Units, and the accretion of redeemable shares to their redemption value.
- Liabilities: Current liabilities increased to $115,476, primarily due to accrued offering costs and amounts due to the Sponsor.
- Over-Allotment: On February 19, 2026, underwriters elected to forfeit their over-allotment option, resulting in the forfeiture of 500,000 Founder Shares and the derecognition of a $422,000 over-allotment liability.
Outlook, Risks, and Management Commentary
Outlook and Strategy: The Company has 21 months from the IPO closing (February 17, 2026) to consummate a business combination. Management intends to use substantially all funds in the Trust Account to complete a transaction. On March 17, 2026, the Company entered into a non-binding letter of intent with a prospective target, though no definitive agreement has been executed.
Liquidity: The Company has sufficient funds to finance working capital needs for at least one year. It holds $933,390 in cash outside the Trust Account for operational expenses. The Sponsor may provide working capital loans up to $1,500,000 if necessary.
Risks and Contingencies:
- Geopolitical Instability: Ongoing conflicts (Russia-Ukraine, Israel-Hamas) and related sanctions could disrupt global markets and the Company's ability to find a target.
- Business Combination Failure: If the Company fails to complete a business combination within 21 months, it will liquidate and redeem public shares from the Trust Account.
- Deferred Underwriting Fees: A deferred underwriting fee of 3.5% of gross proceeds ($3,500,000) is payable only upon the consummation of a business combination.
Investor Verification Checklist
- Verify the status of the non-binding letter of intent signed on March 17, 2026, and whether a definitive agreement has been reached.
- Confirm the 21-month deadline for completing a business combination (approx. November 2027) and any potential extension mechanisms.
- Review the $10,000 monthly administrative fee agreement with the Sponsor and its impact on cash burn outside the Trust Account.
- Monitor the interest rate environment affecting the $100.4 million held in the Trust Account, which currently yields interest income.
- Assess the impact of the forfeited over-allotment option on the final share count and potential dilution.